Mozart Therapeutics, a developer of CD8 Treg modulators for the treatment of autoimmune and inflammatory disease, expanded its executive leadership team with the appointments of Jason Chien, chief medical officer, and Russ Hawkinson as chief financial officer.  Chien brings nearly 30 years of experience in immunology and infectious diseases from his work in academia, healthcare, and the biopharmaceutical industry. He previously served as vice president of respiratory infection R&D strateg...